Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - SHORT-TERM INVESTMENTS
Short-term Investments DNLI - Denali Therapeutics Inc.
907 M
LAST VALUE
25.96%
2 YEAR CAGR
18.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR